{"title":"Nutrition management and self-perceived relapse triggers in patients with inflammatory bowel disease: results from the 3R web-based survey.","authors":"Motohiro Esaki, Takayuki Matsumoto, Fumihito Hirai, Takahiro Suzuki, Yoshiyuki Hosoi, Akira Oota, Masaaki Higashikawa, Minami Umeyama, Masato Ueno","doi":"10.1093/crocol/otag081","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and aims: </strong>Inflammatory bowel disease (IBD), which includes Crohn's disease (CD) and ulcerative colitis (UC), requires long-term management. Besides pharmacotherapy, nutritional care is considered to be important; however, its real-world status in Japan remains unclear.</p><p><strong>Methods: </strong>In this study, a web-based survey on 150 patients with IBD (CD, 75; UC, 75) was conducted between October 30 and November 4, 2025. Patient demographics, self-perceived relapse frequency, self-perceived relapse triggers, implementation of nutritional therapy, and the use of health management apps were evaluated.</p><p><strong>Results: </strong>Patients with CD reported a higher self-perceived relapse frequency than did patients with UC (≥1 episode/year: 52% vs 32%) and were more likely to perceive diet as a self-perceived relapse trigger (77% vs 39%). Nutritional therapy was introduced in 53% of patients with CD and 12% of patients with UC, and 31% of patients with CD were currently using elemental diets. Most patients consumed 300-900 kcal/day, and some reported symptom improvement, although discontinuation was often due to the physician's decision or difficulty in intake. Dietary management awareness was higher in the CD group than in the UC group (77% vs 48%), whereas supplement use showed no significant difference (37% vs 29%). Health app usage was <10%, with common reasons for nonuse being a lack of awareness and perceived necessity.</p><p><strong>Conclusions: </strong>Nutritional therapy is more frequently administered to patients with CD in Japan, suggesting its clinical relevance. Strategies are required to enhance dietary guidance, support the continued use of elemental diets, and promote digital health tools.</p>","PeriodicalId":10847,"journal":{"name":"Crohn's & Colitis 360","volume":"8 3","pages":"otag081"},"PeriodicalIF":1.8000,"publicationDate":"2026-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13424441/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Crohn's & Colitis 360","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/crocol/otag081","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/7/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background and aims: Inflammatory bowel disease (IBD), which includes Crohn's disease (CD) and ulcerative colitis (UC), requires long-term management. Besides pharmacotherapy, nutritional care is considered to be important; however, its real-world status in Japan remains unclear.
Methods: In this study, a web-based survey on 150 patients with IBD (CD, 75; UC, 75) was conducted between October 30 and November 4, 2025. Patient demographics, self-perceived relapse frequency, self-perceived relapse triggers, implementation of nutritional therapy, and the use of health management apps were evaluated.
Results: Patients with CD reported a higher self-perceived relapse frequency than did patients with UC (≥1 episode/year: 52% vs 32%) and were more likely to perceive diet as a self-perceived relapse trigger (77% vs 39%). Nutritional therapy was introduced in 53% of patients with CD and 12% of patients with UC, and 31% of patients with CD were currently using elemental diets. Most patients consumed 300-900 kcal/day, and some reported symptom improvement, although discontinuation was often due to the physician's decision or difficulty in intake. Dietary management awareness was higher in the CD group than in the UC group (77% vs 48%), whereas supplement use showed no significant difference (37% vs 29%). Health app usage was <10%, with common reasons for nonuse being a lack of awareness and perceived necessity.
Conclusions: Nutritional therapy is more frequently administered to patients with CD in Japan, suggesting its clinical relevance. Strategies are required to enhance dietary guidance, support the continued use of elemental diets, and promote digital health tools.
背景和目的:炎症性肠病(IBD),包括克罗恩病(CD)和溃疡性结肠炎(UC),需要长期治疗。除了药物治疗,营养护理也被认为是重要的;然而,它在日本的现实地位尚不清楚。方法:本研究于2025年10月30日至11月4日对150例IBD患者(CD, 75例;UC, 75例)进行网络调查。评估患者人口统计学、自我感知的复发频率、自我感知的复发触发因素、营养治疗的实施以及健康管理应用程序的使用。结果:与UC患者相比,CD患者报告了更高的自我感知复发频率(≥1次/年:52% vs 32%),并且更有可能将饮食视为自我感知的复发触发因素(77% vs 39%)。53%的乳糜泻患者和12%的UC患者采用营养疗法,31%的乳糜泻患者目前使用元素饮食。大多数患者每天消耗300-900千卡,一些患者报告症状有所改善,尽管停药通常是由于医生的决定或摄入困难。乳糜泻组的饮食管理意识高于UC组(77%对48%),而补充剂的使用没有显著差异(37%对29%)。结论:日本乳糜泻患者更常采用营养疗法,提示其临床相关性。需要制定战略,加强饮食指导,支持继续使用基本饮食,并推广数字卫生工具。